Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma.

Zhong JH, Li le Q, Wu LC.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008713. doi: 10.1002/14651858.CD008713.pub2. Review.

PMID:
22161435
2.

Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.

Katz LH, Tur-Kaspa R, Guy DG, Paul M.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD006005. doi: 10.1002/14651858.CD006005.pub2. Review.

PMID:
20614442
3.

Phyllanthus species for chronic hepatitis B virus infection.

Xia Y, Luo H, Liu JP, Gluud C.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD008960. doi: 10.1002/14651858.CD008960.pub2. Review.

PMID:
21491412
4.

Adefovir dipivoxil: a review of its use in chronic hepatitis B.

Dando T, Plosker G.

Drugs. 2003;63(20):2215-34. Review.

PMID:
14498759
5.

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

Peters MG, Hann Hw Hw, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray Df Df, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL.

Gastroenterology. 2004 Jan;126(1):91-101.

PMID:
14699491
6.

Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection.

Qaqish RB, Mattes KA, Ritchie DJ.

Clin Ther. 2003 Dec;25(12):3084-99. Review.

PMID:
14749147
7.

Virological response and hepatocarcinogenesis in lamivudine-resistant hepatitis B virus genotype C patients treated with lamivudine plus adefovir dipivoxil.

Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H.

Intervirology. 2008;51(6):385-93. doi: 10.1159/000203283. Epub 2009 Feb 20.

PMID:
19229115
8.

Interferon alpha for chronic hepatitis D.

Abbas Z, Khan MA, Salih M, Jafri W.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006002. doi: 10.1002/14651858.CD006002.pub2. Review.

PMID:
22161394
9.

Adefovir dipivoxil in the treatment of chronic hepatitis B.

Rivkin AM.

Ann Pharmacother. 2004 Apr;38(4):625-33. Epub 2004 Feb 27. Review.

PMID:
14990784
10.

Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.

Xia Y, Luo H, Liu JP, Gluud C.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009004. doi: 10.1002/14651858.CD009004.pub2. Review.

PMID:
23633363
11.

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.

Weis S, Franke A, Berg T, Mössner J, Fleig WE, Schoppmeyer K.

Cochrane Database Syst Rev. 2015 Jan 26;1:CD006745. doi: 10.1002/14651858.CD006745.pub3. Review.

PMID:
25620061
12.

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.

Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F; Club Epatologi Ospedalieri (CLEO) Group..

Clin Ther. 2008 Feb;30(2):317-23. doi: 10.1016/j.clinthera.2008.02.012.

PMID:
18343270
13.

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.

Schoppmeyer K, Weis S, Mössner J, Fleig WE.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006745. doi: 10.1002/14651858.CD006745.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;1:CD006745.

PMID:
19588401
14.

[A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period].

Yang Q, Gong ZJ, Hu DF.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jul;17(7):515-9. Chinese.

PMID:
19912686
15.

Adefovir dipivoxil in chronic hepatitis B infection.

Yuen MF, Lai CL.

Expert Opin Pharmacother. 2004 Nov;5(11):2361-7. Review.

PMID:
15500383
16.

Bile acids for viral hepatitis.

Chen W, Liu J, Gluud C.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003181. Review.

PMID:
17943781
17.

Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.

Manolakopoulos S, Bethanis S, Koutsounas S, Goulis J, Vlachogiannakos J, Christias E, Saveriadis A, Pavlidis C, Triantos C, Christidou A, Papatheodoridis G, Karamanolis D, Tzourmakliotis D.

Aliment Pharmacol Ther. 2008 Feb 1;27(3):266-73. Epub 2007 Nov 5. Erratum in: Aliment Pharmacol Ther. 2008 Mar 15;27(6):528-9.

18.

Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.

Wiegand J, Tischendorf JJ, Nashan B, Klempnauer J, Flemming P, Niemann P, Rohde P, Manns MP, Trautwein C, Tillmann HL.

Z Gastroenterol. 2004 Jan;42(1):15-8.

PMID:
14997399
19.
20.

Antivirals for the treatment of chronic hepatitis B: current and future options.

Humphries JC, Dixon JS.

Intervirology. 2003;46(6):413-20.

PMID:
14688461

Supplemental Content

Support Center